Actelion-Verkauf - Jean-Paul und Martine Clozel: Das 30-Milliarden-Paar
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
Was plant das Ehepaar Clozel? | NZZ
Jean-Paul Clozel, patron de l'entreprise de biotechnologie Actelion - RTS.ch
Team Actelion. In the 1980s, hundreds of biotechnology… | by Life Sciences at CHF | LSF Magazine | Medium
Jean-Paul Clozel – mit Herzblut für Actelion - Rendez-vous - SRF
Actelion: independent thinking | Financial Times
Jean-Paul Clozel, CEO Actelion - YouTube
Molecular Millionaire: Jean-Paul Clozel of Actelion
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
Actelion Could Boost Takeover Price for Johnson & Johnson
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Actelion wins FDA approval for hypertension drug - San Francisco Business Times
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
We could be the 1st EU-Biopharma entering the Major League"
Actelion: Die Knackpunkte eines Deals mit Johnson & Johnson | Tages-Anzeiger
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Jean-Paul Clozel | EY - Global
Jean-Paul Clozel
Actelion hi-res stock photography and images - Alamy
